WCN26-4522 Celastrol Ameliorates Diabetic Kidney Disease by Suppressing NOX2-Mediated Ferroptosis Signaling

Read full text Summarise with VIRAT
Authors: Tongtong Dai, Donghong Ma, Dandan Wang, Jiao Zhang, Wenchao Li, Chenxi Zeng, Senle Dai
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetic kidney disease (DKD), a leading microvascular complication of diabetes mellitus, is driven by incompletely understood pathomechanisms. Emerging evidence implicates ferroptosis—an iron-dependent, regulated form of cell death—in the onset and progression of DKD. Celastrol, a bioactive quinone methide purified from Tripterygium wilfordii, exerts robust anti-inflammatory and antioxidant effects and has been reported to ameliorate experimental DKD, although its precise molecular targets remain elusive.

Fields of Study & Subjects

Ferroptosis and cancer prognosis Chronic Kidney Disease and Diabetes Natural Compounds in Disease Treatment

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104465–104465
Publication date
25 March 2026
Language
EN